Health care giant Johnson & Johnson has retained UM as its media buyer in North America., the client has confirmed.
The company spent just over $1 billion on ads in the U.S. last year, according to Kantar Media. That was down 14% from the nearly $1.2 billion it spent the prior year, per Kantar.
J&J, which declined to comment on the review yesterday, issued the following statement today concerning the decision: “Johnson & Johnson has completed a review of media planning and buying agencies to support its North America businesses across our Consumer, Medical Device & Diagnostics, and Pharmaceutical sectors and will retain the incumbent agency, J3 (a Universal McCann/IPG company).
"The review began several months ago with the objective of leveraging the company’s scale to identify cost savings and increase value. Johnson & Johnson has partnered with UM since 1973. We look forward to continuing our strong partnership.”
WPP’s MEC and Omnicom’s OMD also participated in the review.
Word of the review in North America follows a separate media review -- for both planning and buying -- that the client wrapped up two weeks ago for the Europe, Middle East and Africa region. J&J’s estimated annual spending in that region is said to be approximately $320 million.
There, J&J awarded the business to two shops, with the majority of it going to a new GroupM entity called Primus. UM was awarded a smaller portion. Carat had been the incumbent on the entire piece of business since 2007.